Skip to main content
Earnings Labs
Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ·Healthcare·Biotechnology

$264.41

+3.59%

Mkt Cap $5.10B

Analyst Ratings

Buy

8

Hold

0

Sell

0

Price Target (16 analysts)

$249.33

Range $230.00$275.00

Implied Upside

-5.7%

Consensus $249.33 vs current $264.41